Cost Analysis of the Treatment of Schizophrenia in the UK: A Comparison of Olanzapine and Haloperidol

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.5, 1998-05, pp. : 575-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol

By Almond S.

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 383-389

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

By Knapp Martin Windmeijer Frank

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 341-358

Adis International

Access to resources Recommend Favorite

Olanzapine: small benefit, greater cost vs haloperidol

Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Olanzapine pamoate for the treatment of schizophrenia

By Naber Dieter

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 627-633

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Ziprasidone versus Haloperidol in Sequential Intramuscular/Oral Treatment of Exacerbation of Schizophrenia: Economic Subanalysis of the ZIMO Trial1 1 On behalf of the ZIMO trial collaborative group (see Acknowledgements).

By Cañas Fernando

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 633-645

Adis International

Access to resources Recommend Favorite